MMAD, aerosol output, aerosol output rate and residual volume describe different parts of nebulizer bench performance. None should be read alone. A useful comparison keeps the exact model, test liquid, fill volume, patient interface, measurement method, time window and stop criterion aligned.

Four terms that answer four different questions

MetricPlain-language meaningQuestion to ask
MMADThe aerodynamic diameter that divides the mass distribution of aerosolized active material into two equal halves.Are the distribution, GSD and respirable or fine-particle results also provided?
Aerosol outputThe mass or volume emitted from the nebulizing system’s outlet for a defined fill volume.What left the outlet, under which fill and stop conditions?
Aerosol output rateThe emitted mass or volume per unit time; the ISO-related NHS Wales description uses the first minute.What time window, units and collection point were used?
Residual volumeThe liquid remaining when the system stops generating aerosol.How was the stop point defined and how was the remainder measured?

MMAD is a midpoint, not a single droplet size

Mass median aerodynamic diameter is a median of a mass distribution. It does not mean that every droplet has the stated diameter. A buyer should read MMAD with the reported spread—often geometric standard deviation—and with a respirable or fine-particle fraction or mass where applicable.

A lower MMAD is not automatically “better.” The intended medicine, device labeling, test setup and complete particle-size distribution matter. Avoid turning one particle-size number into a therapeutic or superiority claim.

Output and output rate are related, but not interchangeable

Aerosol output describes an amount emitted for a defined fill. Aerosol output rate adds time. A generic catalogue term such as “nebulization rate” may have been measured by cup-weight loss, outlet collection or another method, so it should not be assumed to equal an ISO-related outlet measurement.

Ask the supplier to identify the standard, clause or internal method behind the value. Output rate can help a team understand emission speed and plan a workflow, but it is not automatically total delivered dose and it is not a clinical-efficacy result.

Residual volume needs a stop rule

Residual volume is what remains when aerosol generation stops under the stated method. A lower result may mean less liquid remained in that test, but it does not independently prove how much medication reached a patient. Compare the initial fill, stop criterion, measurement method and device orientation alongside the result.

Why aligned test conditions matter

Only compare values when the model and configuration, test liquid or formulation, fill volume, patient interface, airflow or breathing profile, method, collection point, time window, stop criterion, units and sample statistics are materially aligned. If one field is missing, treat the comparison as provisional.

Comparison fieldRecord for product ARecord for product B
Exact model / software / medicine cupSupplier to completeSupplier to complete
Test liquid or formulation and fill volumeSupplier to completeSupplier to complete
Adult mask, child mask or mouthpieceSupplier to completeSupplier to complete
Method, standard and clauseSupplier to completeSupplier to complete
Units, time window and stop criterionSupplier to completeSupplier to complete
Sample size, mean and variabilitySupplier to completeSupplier to complete

What ISO 27427 does—and does not—tell you

ISO 27427:2023 addresses safety and performance testing for general-purpose nebulizing systems, including vibrating-mesh and gas-powered formats. The ISO abstract explicitly says that the document does not specify minimum performance. “Tested according to ISO 27427” therefore identifies a test framework; it does not, by itself, prove clinical superiority or make a product “ISO certified.”

A practical document request

  1. Ask for the released specification for the exact model and configuration.
  2. Request the applicable test report or an approved report extract, not only a catalogue value.
  3. Record the liquid, fill, interface, method, units and sample statistics.
  4. Check that the marketed claim uses the same term as the underlying method.
  5. Review intended use, population, cleaning and medication limitations separately.

Use this framework alongside Mericonn’s nebulizer product page, quality and evidence page, and K254171 scope guide. Exact-model reports can be requested through the project inquiry.